Contemporary etiology and prognosis of dilated non-ischemic cardiomyopathy

Area of Science:

• Cardiology
• Genetics
• Heart Failure Research

Background:

• Non-ischemic dilated cardiomyopathy (NI-DCM) is a significant cause of systolic heart failure, particularly affecting younger individuals.
• Genetic factors contribute to up to 40% of NI-DCM cases, highlighting the importance of familial screening.
• NI-DCM encompasses a diverse range of underlying conditions, necessitating accurate etiological classification for effective patient care.

Purpose of the Study:

• To review the current state of management for patients with non-ischemic dilated cardiomyopathy.
• To emphasize the importance of precise etiological classification in tailoring clinical management and prognostic stratification.
• To discuss advancements in diagnosis and treatment strategies within the context of precision medicine.

Main Methods:

• Review of current literature and clinical practices in NI-DCM management.
• Analysis of the role of genetic background and external triggers in NI-DCM pathogenesis.
• Evaluation of progress in cardiac imaging and familial screening for early detection and risk stratification.

Main Results:

• Prognosis for NI-DCM patients has improved due to advances in medical treatments, device therapy, and earlier diagnosis, especially in familial cases.
• Cardiac imaging and familial screening aid in detecting subtle abnormalities and stratifying arrhythmic risk.
• Understanding the complex interplay between genotype and external factors is crucial for determining the clinical phenotype.

Conclusions:

• Accurate etiological classification is pivotal for managing NI-DCM patients and improving their prognosis.
• Early diagnosis, genetic screening, and a strict follow-up are essential for personalized patient care.
• Continued research into the precise causes of NI-DCM will be necessary for further advancements in treatment.